Intermittent granulocyte colony-stimulating factor for neutropenia management in patients with relapsed or refractory multiple myeloma treated with lenalidomide plus dexamethasone

Haowei (Linda) SunDepartment of Medicine, University of Toronto, Toronto, ON, CanadaCorrespondence[email protected]

Eshetu G. AtenafuPrincess Margaret Hospital, Toronto, ON, Canada

Elizabeth YeboahUniversity of Toronto, Toronto, ON, Canada

Donna E. ReeceMedical Oncology and Hematology, Princess Margaret Hospital, Toronto, ON, Canada

Suzanne TrudelMcLaughlin Centre for Molecular Medicine, Princess Margaret Hospital, Toronto, ON, Canada

Vishal KukretiMedical Oncology and Hematology, Princess Margaret Hospital, Toronto, ON, Canada

Esther Masih-KhanDepartment of Experimental Therapeutics, Toronto General Research Institute, Toronto, ON, Canada

Andrew WinterPrincess Margaret Hospital, Toronto, ON, Canada

Christine ChenMedical Oncology and Hematology, Princess Margaret Hospital, Toronto, ON, Canada

Your download is now in progress and you may close this window